JAK2 activation by growth hormone and other cytokines

MJ Waters, AJ Brooks - Biochemical Journal, 2015 - portlandpress.com
Growth hormone (GH) and structurally related cytokines regulate a great number of
physiological and pathological processes. They do this by coupling their single …

The thrombopoietin receptor: revisiting the master regulator of platelet production

IS Hitchcock, M Hafer, V Sangkhae, JA Tucker - Platelets, 2021 - Taylor & Francis
Thrombopoietin (TPO) and its receptor, MPL, are the primary regulators of platelet
production and critical for hematopoietic stem cell (HSC) maintenance. Since TPO was first …

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants

I Chachoua, C Pecquet, M El-Khoury… - Blood, The Journal …, 2016 - ashpublications.org
Mutations in the calreticulin gene (CALR) represented by deletions and insertions in exon 9
inducing a− 1/+ 2 frameshift are associated with a significant fraction of myeloproliferative …

Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms

M Araki, Y Yang, N Masubuchi… - Blood, The Journal …, 2016 - ashpublications.org
Recurrent somatic mutations of calreticulin (CALR) have been identified in patients
harboring myeloproliferative neoplasms; however, their role in tumorigenesis remains …

Mechanism of activation of protein kinase JAK2 by the growth hormone receptor

AJ Brooks, W Dai, ML O'Mara, D Abankwa, Y Chhabra… - Science, 2014 - science.org
Introduction Class I cytokines regulate key processes such as growth, lactation,
hematopoiesis, and immune function and contribute to oncogenesis. Although the …

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations

S Wilmes, M Hafer, J Vuorio, JA Tucker, H Winkelmann… - Science, 2020 - science.org
Homodimeric class I cytokine receptors are assumed to exist as preformed dimers that are
activated by ligand-induced conformational changes. We quantified the dimerization of three …

Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants

C Pecquet, I Chachoua, A Roy… - Blood, The Journal …, 2019 - ashpublications.org
Abstract Calreticulin (CALR)+ 1 frameshift mutations in exon 9 are prevalent in
myeloproliferative neoplasms. Mutant CALRs possess a new C-terminal sequence rich in …

Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models

RJ Lin, J Sutton, T Bentley, DA Vargas-Inchaustegui… - Science …, 2023 - science.org
The magnitude of CAR T cell expansion has been associated with clinical efficacy. Although
cytokines can augment CAR T cell proliferation, systemically administered cytokines can …

The thrombopoietin receptor: structural basis of traffic and activation by ligand, mutations, agonists, and mutated calreticulin

LN Varghese, JP Defour, C Pecquet… - Frontiers in …, 2017 - frontiersin.org
A well-functioning hematopoietic system requires a certain robustness and flexibility to
maintain appropriate quantities of functional mature blood cells, such as red blood cells and …

[HTML][HTML] Functional consequences of mutations in myeloproliferative neoplasms

SN Constantinescu, W Vainchenker, G Levy… - …, 2021 - journals.lww.com
Driver mutations occur in Janus kinase 2 (JAK2), thrombopoietin receptor (MPL), and
calreticulin (CALR) in BCR-ABL1 negative myeloproliferative neoplasms (MPNs). From …